Tech Pulse Studio Back
A scientist examining a slide under a microscope
← Case studies CS—002 · Medical diagnostics · Europe and US

Telling the story of earlier cancer detection.

Company
Earlier cancer detection, expanding into the US
Engagement
2025 to 2026
Our role
Investor outreach and introductions, advisory boards, story and website

Cancer is far deadlier when it is found late. We built the company’s story around that problem. It raised $1.7M from angel investors and opened doors with US hospitals.

01 · The problem

Found early, most people survive. Most are not found early.

Five-year survival by how far the cancer has spread at diagnosis67% → 12%Non-small cell lung cancer, the most common type
Eligible Americans screenedFewer than 1 in 5Of people who qualify for lung cancer screening
From evidence to everyday practice17 yearsThe average time for proven research to reach patients

Lung cancer shown as an example. Survival: American Cancer Society. Screening: American Lung Association. The 17-year figure is a widely cited estimate of the research-to-practice gap.

02 · The round

$1.7M from angel investors we introduced.

Average cheque~$59K per angelAbout 1,900 reached, 500 met, 29 invested.

Stages shown in order, not to scale.

03 · Into the US

US hospitals in conversation.

The story opened a new pipeline of US hospital partners to generate real-world evidence, all run from one CRM alongside investors and advisors.